Detection of HPV in urine for cervical cancer screening: Feasibilty of an assay system

J Gynecol Obstet Hum Reprod. 2023 Oct;52(8):102631. doi: 10.1016/j.jogoh.2023.102631. Epub 2023 Jul 12.

Abstract

The detection of urine HPV is considered as a promosing alternative to increase the screening coverage of cervical cancer. However, the validated assay of urine HPV is still scarse. We described a nouvel assay syetem for the urine-based detection of HPV in the framework of HPV screening. This sytsem consisted of Automate Nimbus extraction of DNA and Anyplex™ II HPV HR Detection PCR of HPV DNA. We validated this system by spiking HPV-infected cervical cancer cell line HeLa cells into normal urine and compared the prelimary results of cervical samples and urine samples. We found that this system could detect as few as 5 HeLa cells in normal urine model. Some discordances of HPV results between cervical samples and urine samples were observed. We concluded that this assay system could be applied for the detection of HPV in urine. A large scale study is necessary to evaluate the clinical significance of this assay system.

Keywords: Assay; Cervical cancer; HPV; Screening; Urine.

MeSH terms

  • DNA, Viral / genetics
  • DNA, Viral / urine
  • Early Detection of Cancer / methods
  • Female
  • HeLa Cells
  • Humans
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / diagnosis
  • Sensitivity and Specificity
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / prevention & control

Substances

  • DNA, Viral